New insights on Ethambutol Targets in Mycobacterium tuberculosis.

BACKGROUND In recent years, very few effective drugs against Mycobacterium tuberculosis have emerged, which motivates the research with drugs already used in the treatment of tuberculosis. Ethambutol is a bacteriostatic drug that affects cell wall integrity, but the effects of this drug on bacilli are not fully exploited. OBJECTIVE Based on the need to better investigate the complex mechanism of action of ethambutol, our study presented the proteome profile of M. tuberculosis after different times of ethambutol exposure, aiming to comprehend the dynamics of bacilli response to its effects. M. tuberculosis was exposed to ½ MIC of ethambutol at 24 and 48 hours. The proteins were identified by MALDI-TOF/TOF. RESULTS The main protein changes occurred in metabolic proteins as dihydrolipoyl dehydrogenase (Rv0462), glutamine synthetase1 (Rv2220), electron transfer flavoprotein subunit beta (Rv3029c) and adenosylhomocysteinase (Rv3248c). CONCLUSION Considering the functions of these proteins, our results support that the intermediary metabolism and respiration were affected by ethambutol and this disturbance provided proteins that could be explored as additional targets for this drug.

[1]  M. Soliman,et al.  Recent advancements in the development of anti-tuberculosis drugs. , 2017, Bioorganic & medicinal chemistry letters.

[2]  F. Pavan,et al.  Anti-Mycobacterium tuberculosis activity of antituberculosis drugs and amoxicillin/clavulanate combination. , 2016, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.

[3]  E. M. Souza,et al.  Proteomic and morphological changes produced by subinhibitory concentration of isoniazid in Mycobacterium tuberculosis. , 2016, Future microbiology.

[4]  Richard E. Lee,et al.  New agents for the treatment of drug-resistant Mycobacterium tuberculosis. , 2016, Advanced drug delivery reviews.

[5]  C. Nakamura,et al.  Morphological changes and differentially expressed efflux pump genes in Mycobacterium tuberculosis exposed to a rifampicin and verapamil combination. , 2016, Tuberculosis.

[6]  M. Lata,et al.  Comparative Proteomic Analysis of Aminoglycosides Resistant and Susceptible Mycobacterium tuberculosis Clinical Isolates for Exploring Potential Drug Targets , 2015, PloS one.

[7]  A. Jaleel,et al.  Profiling the Proteome of Mycobacterium tuberculosis during Dormancy and Reactivation* , 2015, Molecular & Cellular Proteomics.

[8]  Laura Shackelford,et al.  Early Modern Humans and Morphological Variation in Southeast Asia: Fossil Evidence from Tam Pa Ling, Laos , 2015, PloS one.

[9]  R. B. de Lima Scodro,et al.  In vitro interaction of eupomatenoid-5 from Piper solmsianum C. DC. var. solmsianum and anti-tuberculosis drugs. , 2014, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[10]  S. Mowbray,et al.  Inhibition of Glutamine Synthetase: A Potential Drug Target in Mycobacterium tuberculosis , 2014, Molecules.

[11]  R. F. Cardoso,et al.  Anti-Mycobacterium tuberculosis activity and cytotoxicity of Calophyllum brasiliense Cambess (Clusiaceae) , 2014, Memorias do Instituto Oswaldo Cruz.

[12]  V. Bernardes-Génisson,et al.  Isoniazid: an update on the multiple mechanisms for a singular action. , 2013, Current medicinal chemistry.

[13]  S. Sengupta,et al.  Regulation of homocysteine metabolism by Mycobacterium tuberculosis S-adenosylhomocysteine hydrolase , 2013, Scientific Reports.

[14]  L. Cardozo-Filho,et al.  Anti-tuberculosis neolignans from Piper regnellii. , 2013, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[15]  Connie R. Jimenez,et al.  Proteomic Profiling of Mycobacterium tuberculosis Identifies Nutrient-starvation-responsive Toxin–antitoxin Systems , 2013, Molecular & Cellular Proteomics.

[16]  G. A. Grant.  Contrasting catalytic and allosteric mechanisms for phosphoglycerate dehydrogenases. , 2012, Archives of biochemistry and biophysics.

[17]  D. Sherman,et al.  The multistage vaccine H56 boosts the effects of BCG to protect cynomolgus macaques against active tuberculosis and reactivation of latent Mycobacterium tuberculosis infection. , 2012, The Journal of clinical investigation.

[18]  N. Singhal,et al.  Analysis of intracellular expressed proteins of Mycobacterium tuberculosis clinical isolates , 2012, Proteome Science.

[19]  P. Alzari,et al.  Functional plasticity and allosteric regulation of α-ketoglutarate decarboxylase in central mycobacterial metabolism. , 2011, Chemistry & biology.

[20]  D. Schnappinger,et al.  Virulence of Mycobacterium tuberculosis depends on lipoamide dehydrogenase, a member of three multienzyme complexes. , 2011, Cell host & microbe.

[21]  M. Sun,et al.  The Novel Responses of Ethambutol Against Mycobacterium smegmatis mc2155 Revealed by Proteomics Analysis , 2011, Current Microbiology.

[22]  H. Chandra,et al.  Glutamine synthetase encoded by glnA-1 is necessary for cell wall resistance and pathogenicity of Mycobacterium bovis. , 2010, Microbiology.

[23]  A. van Belkum,et al.  Time-kill kinetics of anti-tuberculosis drugs, and emergence of resistance, in relation to metabolic activity of Mycobacterium tuberculosis. , 2010, The Journal of antimicrobial chemotherapy.

[24]  N. Singhal,et al.  Proteomic analysis of streptomycin resistant and sensitive clinical isolates of Mycobacterium tuberculosis , 2010, Proteome Science.

[25]  Qiang Huang,et al.  Altered protein expression patterns of Mycobacterium tuberculosis induced by ATB107 , 2010, The Journal of Microbiology.

[26]  E. Rødland,et al.  Characterization of the major formamidopyrimidine–DNA glycosylase homolog in Mycobacterium tuberculosis and its linkage to variable tandem repeats , 2009, FEMS immunology and medical microbiology.

[27]  J. Sacchettini,et al.  Structural analysis of substrate and effector binding in Mycobacterium tuberculosis D-3-phosphoglycerate dehydrogenase. , 2008, Biochemistry.

[28]  E. Marcotte,et al.  The proteomic response of Mycobacterium smegmatis to anti-tuberculosis drugs suggests targeted pathways. , 2008, Journal of proteome research.

[29]  A. Whetton,et al.  How will haematologists use proteomics? , 2007, Blood reviews.

[30]  G. A. Grant,et al.  A Novel Mechanism for Substrate Inhibition in Mycobacterium tuberculosis d-3-Phosphoglycerate Dehydrogenase* , 2007, Journal of Biological Chemistry.

[31]  Scott J Geromanos,et al.  Quantitative proteomic analysis of drug-induced changes in mycobacteria. , 2006, Journal of proteome research.

[32]  L. Jia,et al.  Pharmacoproteomic Effects of Isoniazid, Ethambutol, and N-Geranyl-N′-(2-adamantyl)ethane-1,2-diamine (SQ109) on Mycobacterium tuberculosis H37Rv , 2005, Journal of Pharmacology and Experimental Therapeutics.

[33]  Makoto Suematsu,et al.  Variant tricarboxylic acid cycle in Mycobacterium tuberculosis: identification of alpha-ketoglutarate decarboxylase. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[34]  Sanghamitra Dey,et al.  Crystal Structure of Mycobacterium tuberculosis D-3-Phosphoglycerate Dehydrogenase , 2005, Journal of Biological Chemistry.

[35]  Graham F Hatfull,et al.  Integration and excision by the large serine recombinase φRv1 integrase , 2005, Molecular microbiology.

[36]  R. Marouga,et al.  Protein Detection Methods in Proteomics Research , 2005, Bioscience reports.

[37]  J. Starck,et al.  Comparative proteome analysis of Mycobacterium tuberculosis grown under aerobic and anaerobic conditions. , 2004, Microbiology.

[38]  E. Rubin,et al.  Genes required for mycobacterial growth defined by high density mutagenesis , 2003, Molecular microbiology.

[39]  S. Cole,et al.  Proteome Analysis of the Plasma Membrane of Mycobacterium Tuberculosis , 2002, Comparative and functional genomics.

[40]  F. Portaels,et al.  Resazurin Microtiter Assay Plate: Simple and Inexpensive Method for Detection of Drug Resistance in Mycobacterium tuberculosis , 2002, Antimicrobial Agents and Chemotherapy.

[41]  V. Neuhoff,et al.  Improved staining of proteins in polyacrylamide gels including isoelectric focusing gels with clear background at nanogram sensitivity using Coomassie Brilliant Blue G‐250 and R‐250 , 1988, Electrophoresis.

[42]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.